Eligibility for NHS Continuing Healthcare (NHS CHC) is not limited by the setting in which the package of support can be offered or by the type of service delivery.<\/p>
<\/p>
When making decisions about eligibility for NHS CHC there is no distinction drawn between individuals residing in hospices and those in nursing homes.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"} } , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"} , "dateOfAnswer" : {"_value" : "2016-11-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-11-08T15:13:07.227Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-10-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Continuing Care"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government whether NHS-funded continuing healthcare is available for hospice patients receiving palliative care; and what distinction, if any, is drawn between patients in hospices and those in nursing homes in determining the availability of continuing healthcare.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2489", "label" : {"_value" : "Biography information for Baroness Massey of Darwen"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Massey of Darwen"} ], "uin" : "HL2684"} , {"_about" : "http://data.parliament.uk/resources/621911", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/621911/answer", "answerText" : {"_value" : "
For the last 12 months for which data is available, (the period 1 April 2015 to 31 March 2016) 992 general practitioners retired and claimed retirement benefits from the NHS Pension Scheme in England and Wales.<\/p>
<\/p>
Of these, 580 were under 60 years of age.<\/p>
<\/p>
General practitioners, in common with other staff groups, are able to claim retirement benefits and return to the National Health Service. This may be on a full time or part-time basis. This is common practice but exact numbers are not known.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"} } , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"} , "dateOfAnswer" : {"_value" : "2016-11-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-11-08T15:11:45.83Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-10-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "General Practitioners: Retirement"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government how many general practitioners in England retired during the past 12 months; and, of those, how many were aged under 60 at the time of retirement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/547", "label" : {"_value" : "Biography information for Lord Wigley"} } , "tablingMemberPrinted" : [{"_value" : "Lord Wigley"} ], "uin" : "HL2717"} , {"_about" : "http://data.parliament.uk/resources/621936", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/621936/answer", "answerText" : {"_value" : "
The Human Fertilisation and Embryology Authority has advised that it has nothing further to add, in respect of the correspondence between Professor Grifo and the expert panel, to that already set out in previous answers.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"} } , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"} , "dateOfAnswer" : {"_value" : "2016-11-07", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL2544"} , {"_value" : "HL2611"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-11-07T14:22:33.843Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-10-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government, further to the Written Answer by Lord Prior of Brampton on 11 July 2016 (HL1098), whether the correspondence between Professor Grifo and the Human Fertilisation and Embryology Authority (HFEA) expert panel was selectively released to anyone not directly connected with the HFEA; whether other information received by the HFEA has been selectively released to such persons but not otherwise made publicly available; and if so, what assessment they have made of the extent to which conflicts of interest might arise from the selective release of such material.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL2742"} , {"_about" : "http://data.parliament.uk/resources/621944", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/621944/answer", "answerText" : {"_value" : "
The Department does not hold data that distinguishes emergency from non-emergency healthcare provided to patients subject to the NHS (Charges to Overseas Visitors) Regulations 2015.<\/p>
<\/p>
The Department does not hold information on the numbers of persons estimated to travel to the United Kingdom specifically for the purpose of accessing National Health Service services.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"} } , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"} , "dateOfAnswer" : {"_value" : "2016-11-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-11-01T16:11:45.987Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-10-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: Foreign Nationals"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what is the anual cost to the NHS of (1) people coming to the UK from overseas to receive non-emergency medical treatment, and (2) non-UK residents receiving emergency healthcare; and how many such persons are estimated to travel to the UK specifically for the purpose of accessing NHS services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/259", "label" : {"_value" : "Biography information for The Marquess of Lothian"} } , "tablingMemberPrinted" : [{"_value" : "The Marquess of Lothian"} ], "uin" : "HL2750"} , {"_about" : "http://data.parliament.uk/resources/621947", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/621947/answer", "answerText" : {"_value" : "
The Department welcomed Dame Fiona Caldicott\u2019s Review of Data Security, Consents and Opt-Outs<\/em> and, following conclusion of a public consultation exercise, will respond to all recommendations in due course.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
, "dateOfAnswer" : {"_value" : "2016-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-11-03T13:28:16Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-10-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medical Records: Data Protection"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty\u2019s Government which of the recommendations of the Review by the National Data Guardian for Health and Care of Data Security, Consents and Opt-Outs published in June they intend to treat as formal recommendations to which they will provide a response.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"}
], "uin" : "HL2753"}
, {"_about" : "http://data.parliament.uk/resources/621975", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/621975/answer", "answerText" : {"_value" : " The National Institute for Health and Care Excellence (NICE) has appraised the PCSK9 inhibitors alirocumab (Praluent) and evolocumab (Repatha) for treating primary hypercholesterolaemia and mixed dyslipidaemia. In June 2016, NICE issued final technology appraisal guidance recommending both treatments, subject to certain criteria. Further information is available at:<\/p> <\/p>